United Therapeutics Jumps on Strong Tyvaso Trial Results in Pulmonary Fibrosis

United Therapeutics surged about 12% in Monday morning trading after reporting positive data from two studies evaluating Tyvaso (treprostinil) in... Read More
The post United Therapeutics Jumps on Strong Tyvaso Trial Results in Pulmonary Fibrosis appeared first on citybiz.
